GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, FABP3, GLRA1, GSK3B, HSD17B2, IDO1, IGF1R, MMP2, MMP9, PPARA, PPARD, PTGS2, RORC, SRC, TYR |
10.075 |
[BP] GO:0010033 |
response to organic substance
|
ADORA2A, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, FABP3, FABP4, FLT3, GLRA1, GSK3B, HSD17B2, IDO1, IGF1R, KDR, MMP2, PPARA, PPARD, PTGS2, RORC, SRC, TYR |
10.0525 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ADORA2A, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, FABP3, FABP4, FLT3, GLRA1, GSK3B, HSD17B2, IDO1, IGF1R, KDR, MMP2, MMP9, PPARA, PPARD, PTGS2, RORC, SRC, TERT, TYR |
10.0525 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, ADORA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, GSK3B, HCAR2, IDO1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH |
9.65531 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GSK3B, HCAR2, KDR, MET, MIF, MMP12, MMP9, PPARD, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
9.65531 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GSK3B, HCAR2, KDR, MET, MIF, MMP12, MMP9, PPARD, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
9.65531 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, ADORA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, GSK3B, HCAR2, IDO1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARD, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH |
9.65531 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA2A, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLRA1, GSK3B, HCAR2, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
9.63893 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, GLRA1, KDR, MMP9, PTGS2, SRC, TERT |
9.61663 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, SRC, TERT |
9.41498 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARD, PTGS2, PTPN1, SRC, TERT |
9.20957 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, ADORA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, GSK3B, HCAR2, IDO1, IGF1R, KDR, MIF, MMP9, PIM1, PPARD, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH |
9.01269 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, ADORA2A, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, GLRA1, GSK3B, HCAR2, HSD17B1, HSD17B2, KDR, MET, MIF, PPARA, PPARD, PTGS2, SRC, TERT, TNKS, TNKS2, XDH |
9.01177 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, FABP3, FLT3, GSK3B, HCAR2, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
8.66138 |
[BP] GO:0044281 |
small molecule metabolic process
|
ADORA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GLO1, IDO1, MIF, PIM1, PPARA, PPARD, PTGS2, TYR, XDH |
8.66138 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, GSK3B, IDO1, IGF1R, KDR, MIF, MMP9, PIM1, PPARD, PTGS2, PTPN1, SRC, TERT |
8.46338 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLO1, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
8.22698 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DYRK1A, FABP4, FLT3, GLO1, GSK3B, HSD17B2, KDR, MET, MIF, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPRS, RORC, SRC, TERT, TNKS2, TOP2A, TYR |
7.87351 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, GLO1, GLRA1, GSK3B, IDO1, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
7.8617 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, GLO1, GLRA1, GSK3B, HCAR2, IDO1, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
7.8617 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, HSD17B1, HSD17B2, MET, MIF, PPARA, PPARD, PTGS2 |
7.65436 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, FABP4, FLT3, GLRA1, GSK3B, IGF1R, KDR, MMP2, MMP9, PPARD, PTGS2, RORC, SRC, TERT |
7.61048 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA2A, ADORA3, AKR1B1, APP, BCL2, CDC25B, CSNK2A1, CYP1B1, DNMT1, FABP3, FLT3, IDO1, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PPARD, PTGS2, SRC, TERT, XDH |
7.59645 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, FLT3, GLRA1, GSK3B, HCAR2, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARD, PTGS2, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
7.59645 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, ADORA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLO1, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP2, PIM1, PPARA, PPARD, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
7.59645 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GSK3B, KDR, MET, MIF, MMP12, MMP9, PPARD, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
7.49762 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, FLT3, GLRA1, GSK3B, HCAR2, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARD, PTGS2, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
7.47604 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, HSD17B1, HSD17B2, IDO1, PPARD, PTGS2, TYR, XDH |
7.35844 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, ADORA2A, APP, CYP19A1, DHFR, DYRK1A, FABP4, GSK3B, IDO1, IGF1R, MET, MIF, MMP12, MMP2, PPARA, PPARD, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH |
7.00293 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, FABP4, FLT3, GLRA1, GSK3B, IGF1R, KDR, MIF, MMP2, MMP9, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A |
6.86436 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, FABP4, FLT3, GLRA1, GSK3B, IGF1R, KDR, MMP2, PPARD, PTGS2, RORC, SRC |
6.86222 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ADORA2A, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DHFR, DYRK1A, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, PPARD, PTGS2, PTPN1, PTPRS, SRC, TNKS, XDH |
6.8257 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.68429 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, FABP4, FLT3, GSK3B, IDO1, KDR, MET, MIF, MMP12, MMP2, MMP9, PPARD, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
6.61541 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, FABP3, FABP4, FLT3, GLRA1, GSK3B, HSD17B2, IDO1, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, TYR |
6.50453 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ADORA2A, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DHFR, DYRK1A, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, PPARD, PTGS2, PTPN1, PTPRS, SRC, TNKS, XDH |
6.43591 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLO1, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
6.39538 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, MIF, PTGS2 |
6.24351 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, GSK3B, HCAR2, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTGS2, PTPN1, SRC, TERT |
6.24351 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, IDO1, PPARD, PTGS2, RORC, SRC, TYR |
6.17468 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ADORA2A, ALPL, APEX1, APP, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FLT3, PTGS2, RORC, SRC, TYR |
6.14071 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, DHFR |
6.04649 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, MIF, PTGS2 |
6.04645 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, APP, BCL2, CA2, CSNK2A1, CYP1A2, DNMT1, FABP3, FLT3, GLRA1, GSK3B, IGF1R, MMP2, PPARA, PTGS2, SRC |
5.99324 |
[BP] GO:0010243 |
response to organonitrogen compound
|
ADORA2A, AKR1B1, APEX1, APP, DHFR, DNMT1, FABP3, FLT3, GLRA1, GSK3B, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
5.89111 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PPARA, PPARD, PTGS2 |
5.8104 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MIF, MMP9, PPARD, PTGS2, SRC, TERT |
5.8104 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA2A, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MIF, MMP9, PPARD, PTGS2, SRC, TERT |
5.80968 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADORA2A, AURKB, BCL2, CA2, CA7, HCAR2, KDR, MIF, PTGS2, SRC, TNKS, TNKS2 |
5.69921 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, IDO1, MIF, PPARA, PPARD, PTGS2 |
5.67314 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLO1, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
5.67314 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DHFR, DYRK1A, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP9, PPARA, PPARD, PTGS2, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
5.64878 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.58982 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, GLRA1, MMP9, PTGS2, TERT |
5.53235 |
[BP] GO:1901698 |
response to nitrogen compound
|
ADORA2A, AKR1B1, APEX1, APP, DHFR, DNMT1, FABP3, FLT3, GLRA1, GSK3B, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
5.50112 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, PPARD |
5.50112 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MIF, MMP9, PPARD, PTGS2, SRC, TERT |
5.49663 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADORA2A, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DHFR, DNMT1, DYRK1A, FABP3, FLT3, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.45741 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, ADORA2A, APP, AXL, BCL2, CA2, CYP19A1, GSK3B, HCAR2, MIF, MMP12, PPARD, PTGS2, SRC, TERT |
5.38623 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADORA2A, APEX1, APP, AURKB, BCL2, CSNK2A1, DHFR, DNMT1, DYRK1A, FABP4, GSK3B, HCAR2, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
5.35415 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADORA2A, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.33997 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GLO1, IDO1, MIF, PIM1, PPARA, PPARD, PTGS2, TYR |
5.26755 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, PIM1, SRC |
5.25044 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CYP1B1, DNMT1, GLRA1, GSK3B, IGF1R, MMP2, MMP9, PPARD, PTGS2, RORC, SRC |
5.18524 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
5.12054 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, GSK3B, MET, MMP9, PPARA, SRC, TERT |
5.10509 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DYRK1A, FLT3, GSK3B, HSD17B2, KDR, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPRS, RORC, SRC, TYR |
5.10377 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MIF, MMP9, PPARD, PTGS2, SRC, TERT |
5.07228 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADORA2A, ALOX15, APP, AURKB, BCL2, CDC25B, DNMT1, DYRK1A, FABP3, FLT3, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.02641 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, FABP4, GLRA1, HSD17B2, IDO1, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, RORC, SRC, TNKS2, TYR |
5.01865 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADORA2A, ALOX15, BCL2, CYP19A1, DYRK1A, GSK3B, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH |
4.89648 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, MIF, PTGS2 |
4.88976 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GLO1, IDO1, MIF, PIM1, PPARA, PPARD, PTGS2, TYR |
4.74083 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ADORA2A, ALOX15, APP, AXL, BCL2, CA2, CA7, CYP19A1, GSK3B, HCAR2, MIF, MMP12, MMP9, PPARA, PPARD, PTGS2, PTPN1, SRC, TERT |
4.69055 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, MET, MIF, PPARA, PPARD, PTGS2 |
4.65145 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GLO1, IDO1, MIF, PIM1, PPARA, PPARD, PTGS2, TYR |
4.65041 |
[BP] GO:0009636 |
response to toxic substance
|
ADORA2A, AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, GLRA1, KDR, SRC |
4.65041 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, FLT3, KDR, MET, MIF, PPARD, PTGS2, PTPN1, SRC, XDH |
4.59293 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DHFR, DNMT1, FABP3, GLRA1, HSD17B2, KDR, MMP2, PTGS2, SRC |
4.55704 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DHFR, PPARD, TYR |
4.53644 |
[BP] GO:0042493 |
response to drug
|
ABCB1, ADORA2A, AKR1B1, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DHFR, FABP3, GLRA1, KDR, PTGS2, SRC |
4.53644 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, ADORA2A, AKR1B1, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DHFR, DYRK1A, FLT3, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, PTPRS, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
4.4831 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.47341 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DHFR, PPARA, PPARD |
4.46483 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADORA2A, APEX1, APP, AURKB, BCL2, CSNK2A1, DHFR, DNMT1, DYRK1A, FABP4, GSK3B, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.46125 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
4.42893 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PPARD, PTGS2, TERT |
4.39225 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADORA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARD, PTGS2, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
4.36338 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PPARD, PTGS2, SRC, TERT |
4.35994 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, GSK3B, MET, MMP9, PPARA, SRC, TERT, TNKS |
4.35883 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA2A, ADORA3, APP, AURKB, CSNK2A1, CYP1B1, FABP4, GSK3B, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS |
4.35883 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PPARD, PTGS2, SRC, TERT |
4.26518 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, FLT3, IGF1R, KDR, MET, MIF, MMP9, PPARD, PTGS2, PTPN1, SRC, XDH |
4.25829 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, GSK3B, IDO1, MMP1, MMP12, MMP2, MMP9, PPARD, SRC, XDH |
4.20259 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, ADORA2A, CA2, CA7, MIF |
4.17858 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, IDO1, MIF, MMP2, MMP9, PPARA, PPARD, PTGS2, PTPN1, SRC, TERT, TOP2A |
4.17724 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC, TNKS |
4.12524 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DYRK1A, GSK3B, PPARA, RORC, SRC, TOP2A |
4.06776 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PPARD, PTGS2, SRC, TERT |
3.98308 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADORA2A, ALPL, APP, AXL, BCL2, CBR1, CDC25B, CYP1A1, FABP4, FLT3, GLO1, GSK3B, KDR, MET, MIF, MMP2, MMP9, PPARD, PTGS2, PTPRS, RORC, SRC, TERT, TOP2A |
3.97108 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, GLRA1, MMP9, PTGS2 |
3.91286 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, DNMT1, GLRA1, GSK3B, IGF1R, MMP2, PTGS2, SRC |
3.85133 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTGS2, PTPN1, SRC |
3.83883 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
ADORA2A, APEX1, APP, AURKB, CSNK2A1, DHFR, DNMT1, DYRK1A, FABP4, GSK3B, IGF1R, KDR, MIF, MMP12, MMP9, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.83883 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DYRK1A, GLRA1, GSK3B, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH |
3.83883 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DYRK1A, GLRA1, GSK3B, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH |
3.82372 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
ADORA2A, AURKB, CA2, CA7, HCAR2, PTGS2, TNKS, TNKS2 |
3.79912 |
[BP] GO:0040013 |
None
|
ADORA1, ADORA2A, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, MIF, PPARD |
3.78748 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADORA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HCAR2, HSD17B1, HSD17B2, PPARD |
3.77654 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, ADORA2A, APP, BCL2, GSK3B, HCAR2, MIF, MMP12, PPARD, PTGS2, SRC |
3.73398 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
3.73398 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.69755 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA, PPARD |
3.67535 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, KDR, PPARA, PPARD, PTPRS, SRC, TYR |
3.62378 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DHFR, DYRK1A, GSK3B, IGF1R, MET, MIF, PTGS2, PTPN1, PTPRS, TERT, XDH |
3.60674 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, DNMT1, GLRA1, GSK3B, IGF1R, MMP2, PTGS2, SRC |
3.5959 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CYP1A1, FLT3, MET, MIF, PIM1, PPARD, SRC, TYR |
3.58018 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.58018 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.58018 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.58018 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, GLRA1, HSD17B2, IDO1, MMP2, MMP9, PPARD, PTGS2, SRC, TOP2A |
3.57827 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ADORA2A, CYP19A1, FABP4, IDO1, KDR, MET, MIF, MMP12, PPARA, PPARD, PTGS2, PTPRS |
3.5725 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLO1, GLRA1, GSK3B, HCAR2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH |
3.5725 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, PPARA, PTGS2, SRC |
3.5725 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, FABP4, GLRA1, MMP9, PTGS2 |
3.57226 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, ADORA2A, CYP19A1, FABP4, IDO1, MMP12, MMP2, PPARA, PPARD, PTGS2, PTPN1, PTPRS, SRC |
3.56209 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, FABP3, GLRA1, PPARA, PPARD |
3.56209 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC |
3.54773 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, MMP9, PTGS2, SRC |
3.51838 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, MIF, PPARD, PTGS2 |
3.51838 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, ADORA2A, HCAR2, MIF, MMP12, PPARD, SRC |
3.5085 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, GSK3B, IGF1R, PPARA, PTGS2, SRC |
3.46426 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, APP, CYP1A1, CYP1B1, FLT3, PTGS2, RORC, SRC |
3.44956 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADORA2A, APP, CA2, GSK3B, HCAR2, MIF, MMP12, PPARD, PTGS2, PTPN1, SRC |
3.44477 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA2A, ADORA3, APP, AXL, BCL2, CA2, CYP1B1, GLRA1, GSK3B, HCAR2, IDO1, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARD, PTGS2, PTPRS, SRC, TERT, TNKS2, XDH |
3.44086 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.4086 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, MIF, PPARD |
3.4086 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADORA2A, ALOX15, APP, BCL2, CDC25B, FABP3, FLT3, KDR, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
3.4086 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADORA2A, ALOX15, APP, BCL2, CDC25B, FABP3, FLT3, KDR, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
3.4086 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, FLT3, IGF1R, KDR, MET, SRC |
3.4086 |
[BP] GO:0001973 |
None
|
ADORA1, ADORA2A, ADORA3 |
3.4086 |
[BP] GO:0014910 |
regulation of smooth muscle cell migration
|
APEX1, BCL2, PPARD, SRC, TERT |
3.408 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, GLRA1, KDR |
3.40048 |
[BP] GO:0051172 |
None
|
ADORA2A, APEX1, APP, AURKB, CSNK2A1, DHFR, DNMT1, DYRK1A, FABP4, IGF1R, MIF, MMP12, MMP9, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.38928 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADORA2A, APP, CA2, CA7, PTGS2 |
3.38461 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, FLT3, IGF1R, KDR, MET, SRC |
3.38029 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, PPARD |
3.38029 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HCAR2, PPARA, PTGS2, RORC, SRC |
3.38029 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA2A, ADORA3, APP, BCL2, CYP1B1, FABP3, IDO1, PPARD, PTGS2, TERT, XDH |
3.37309 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, IDO1 |
3.3645 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADORA2A, CA2, CA7 |
3.32009 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, PPARD, PTGS2, SRC |
3.31288 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.28951 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.28951 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, MIF, PPARD |
3.28559 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, ADORA2A, APP, GSK3B, HCAR2, MIF, MMP12, PPARD, PTGS2, SRC |
3.28507 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PPARD, PTGS2, TERT |
3.27464 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, GLRA1, KDR, PTGS2, SRC |
3.27223 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
ADORA2A, BCL2, GSK3B, MIF, MMP9, PTGS2, PTPN1, SRC, TERT |
3.24074 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, MMP2, PPARA, PPARD, PTGS2, SRC, TERT, TYR |
3.2403 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC, TNKS |
3.23841 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, ADORA2A, CYP19A1, HCAR2, MIF, MMP12, PPARD, SRC |
3.23841 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA2A, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLO1, GSK3B, HCAR2, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.23138 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
ADORA2A, BCL2, CYP1B1, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SRC, TOP2A, XDH |
3.22747 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
3.19632 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
ADORA2A, BCL2, CYP1B1, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SRC, TOP2A, XDH |
3.19145 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, DNMT1, GSK3B, KDR, MET, MMP9, SRC, TNKS, TNKS2 |
3.18027 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA2A, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLO1, GSK3B, HCAR2, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.17605 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, MET, SRC, TNKS, TOP2A |
3.17605 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, DNMT1, GSK3B, IGF1R, KDR, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
3.17152 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, ADORA2A, BCL2, CA2, CA7, KDR, SRC |
3.16895 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, DYRK1A, GSK3B, TNKS |
3.15819 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, MIF, PPARD |
3.15563 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, PPARD, PTGS2, SRC |
3.15563 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADORA2A, APP, BCL2, CSNK2A1, GSK3B, HCAR2, MIF, MMP12, PPARD, PTGS2, PTPN1, SRC, TERT |
3.15317 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTGS2, PTPN1, SRC, TERT |
3.14343 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADORA2A, ALOX15, APP, BCL2, CDC25B, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
3.14343 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, MIF, PTGS2 |
3.13321 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADORA2A, APP, BACE1, CA2, CA7, PTGS2 |
3.11916 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADORA2A, APP, BACE1, CA2, CA7, PTGS2 |
3.11916 |
[BP] GO:0007566 |
embryo implantation
|
MMP2, MMP9, PPARD, PTGS2 |
3.09231 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLO1, GLRA1, GSK3B, HCAR2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.08264 |
[BP] GO:2000106 |
regulation of leukocyte apoptotic process
|
AURKB, AXL, HCAR2, IDO1, MIF |
3.08264 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, PPARD, PTGS2, TYR |
3.08264 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DYRK1A, IGF1R, MET, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
3.08264 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ADORA2A, ALOX15, AXL, CYP19A1, IDO1, MIF, MMP12, PTPRS |
3.08264 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CYP1B1, DHFR, GSK3B, MIF, MMP9, PPARD, PTGS2, PTPN1, SRC, TERT, TOP2A |
3.08224 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, MIF, SRC, TNKS, TNKS2 |
3.05865 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADORA2A, APP, AXL, BCL2, CA2, CYP1B1, HCAR2, IDO1, KDR, MET, MIF, MMP12, MMP9, PIM1, PTGS2, SRC, TERT |
3.05865 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DNMT1, DYRK1A, FLT3, KDR, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
3.05865 |
[BP] GO:1901989 |
None
|
APEX1, APP, CDC25B, CYP1A1, TERT |
3.04477 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
BCL2, CSNK2A1, DYRK1A, GSK3B, TNKS |
3.0215 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADORA2A, ALOX15, APP, BCL2, CDC25B, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
3.02087 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.01332 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADORA2A, CA2, CA7 |
3.01332 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADORA2A, ALOX15, APP, BCL2, CDC25B, FABP3, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
2.96675 |
[BP] GO:0010942 |
positive regulation of cell death
|
ADORA2A, BCL2, CYP1B1, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SRC, TOP2A, XDH |
2.95703 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA2A, ADORA3, APP, AURKB, BCL2, CDC25B, CSNK2A1, DHFR, FABP4, FLT3, GSK3B, IGF1R, MIF, MMP9, PTGS2, PTPN1, SRC, TERT, TNKS, XDH |
2.95371 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, MIF, PTGS2, TERT |
2.93828 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADORA2A, ALOX15, APP, BCL2, CDC25B, FABP3, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
2.92643 |
[BP] GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
ADORA2A, CSNK2A1, MMP9, PTGS2, SRC |
2.91894 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, FLT3, KDR, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
2.90246 |
[BP] GO:0050714 |
None
|
ACHE, ADORA2A, HCAR2, MIF, MMP12, PPARD, SRC |
2.8992 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA2A, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.87335 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADORA2A, ALOX15, APP, BCL2, CDC25B, DNMT1, DYRK1A, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
2.87335 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTGS2, PTPN1, SRC |
2.86499 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, DHFR, IDO1, MIF, PTGS2 |
2.85736 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, DNMT1, FLT3, GLRA1, GSK3B, IGF1R, MMP2, PTGS2, SRC |
2.84843 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.845 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.84104 |
[BP] GO:0070201 |
None
|
ACHE, ADORA2A, APP, BCL2, GSK3B, HCAR2, MIF, MMP12, PPARD, PTGS2, PTPN1, SRC |
2.82065 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA2A, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, MIF, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2 |
2.81951 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, FLT3, GSK3B, KDR, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
2.80303 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA2A, ADORA3, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DHFR, FABP4, FLT3, GSK3B, IGF1R, MET, MIF, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, TNKS, XDH |
2.80044 |
[BP] GO:2000107 |
negative regulation of leukocyte apoptotic process
|
AURKB, AXL, IDO1, MIF |
2.79203 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DYRK1A, GSK3B, SRC, TNKS |
2.78101 |
[BP] GO:0042752 |
None
|
ADORA1, ADORA2A, PPARA, RORC, TOP2A |
2.77494 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.77494 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.73979 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, FLT3, KDR, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
2.73754 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA2A, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.73648 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, ADORA2A, CYP19A1, MMP12, PPARA, PPARD |
2.70515 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.70173 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA2A, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.68976 |
[BP] GO:1903532 |
None
|
ACHE, ADORA2A, CYP19A1, HCAR2, MIF, MMP12, PPARD, SRC |
2.688 |
[BP] GO:0071456 |
cellular response to hypoxia
|
BCL2, PPARD, PTGS2, SRC, TERT |
2.66618 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.65757 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, MIF, PIM1, PTGS2, SRC, TERT, TNKS, TOP2A |
2.64927 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADORA2A, APP, AURKB, CDC25B, FABP4, FLT3, GSK3B, IGF1R, MIF, PTPN1, SRC, TNKS |
2.63465 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, PPARD |
2.61327 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.61327 |
[BP] GO:0046394 |
None
|
ALOX15, ALOX5, CYP1A1, DHFR, IDO1, MIF, PTGS2 |
2.60973 |
[BP] GO:0016053 |
None
|
ALOX15, ALOX5, CYP1A1, DHFR, IDO1, MIF, PTGS2 |
2.60093 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DYRK1A, GSK3B, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH |
2.58728 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CDC25B, CYP1A1, MIF, SRC, TERT |
2.58419 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.58419 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, ADORA2A, APP, BCL2, CA2, CA7, MIF, MMP9, PTGS2 |
2.58041 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.58041 |
[BP] GO:2000117 |
negative regulation of cysteine-type endopeptidase activity
|
ADORA2A, CSNK2A1, MMP9, PTGS2, SRC |
2.57577 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ADORA2A, ALOX15, APP, AXL, BCL2, CA2, CYP19A1, HCAR2, IDO1, MIF, MMP12, MMP2, PTPN1, PTPRS, SRC |
2.56767 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.56571 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, DYRK1A, GSK3B, SRC, TNKS |
2.56569 |
[BP] GO:0036294 |
cellular response to decreased oxygen levels
|
BCL2, PPARD, PTGS2, SRC, TERT |
2.56569 |
[BP] GO:2001251 |
None
|
DNMT1, SRC, TNKS, TNKS2, TOP2A |
2.56569 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DNMT1, DYRK1A, FLT3, GSK3B, KDR, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
2.56569 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, FABP3, FABP4, FLT3, MET, SRC, TERT |
2.56569 |
[BP] GO:1901215 |
negative regulation of neuron death
|
ADORA2A, AXL, BCL2, GSK3B, PPARA, TERT |
2.54571 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA2A, ADORA3 |
2.52606 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.51641 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, ADORA2A, CYP19A1, MIF, PPARA, PPARD, PTPRS |
2.51311 |
[BP] GO:0050789 |
regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLO1, GLRA1, GSK3B, HCAR2, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.51311 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.50696 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, ADORA2A, CYP19A1, PPARA, PPARD |
2.50414 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, ADORA2A, CYP19A1, FABP4, IDO1, PPARA, PPARD, PTGS2 |
2.47389 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, TERT, TNKS, TNKS2 |
2.47339 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.47339 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.47339 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, APP, AURKB, BCL2, CDC25B, DHFR, FLT3, GSK3B, MET, MIF, MMP9, PTPN1, SRC, TERT, TNKS, XDH |
2.46987 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.46121 |
[BP] GO:0006909 |
phagocytosis
|
ADORA1, ADORA2A, ALOX15, AXL |
2.45095 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.45095 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, DNMT1, GSK3B, IGF1R, KDR, MET, MMP1, MMP9, PPARD, PTPN1, PTPRS, SRC, TNKS, TNKS2, TOP2A |
2.4472 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, FLT3, KDR, MIF, PTPN1, SRC, XDH |
2.44438 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.42968 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.42968 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ADORA2A, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, PTPRS, SRC, TNKS, TNKS2, TOP2A |
2.4264 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.4264 |
[BP] GO:0051223 |
None
|
ACHE, ADORA2A, APP, GSK3B, HCAR2, MIF, MMP12, PPARD, PTGS2, PTPN1, SRC |
2.41251 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC |
2.39019 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.3723 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, PPARD |
2.36403 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.36403 |
[BP] GO:0051881 |
regulation of mitochondrial membrane potential
|
ADORA2A, BCL2, KDR, SRC |
2.36403 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.36403 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, IDO1 |
2.35565 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, APP, AURKB, BCL2, CDC25B, CYP1A1, PIM1, TERT, TNKS, TOP2A |
2.35038 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.35038 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.35038 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
ADORA2A, CSNK2A1, MMP9, PTGS2, SRC, XDH |
2.34966 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.34558 |
[BP] GO:0071453 |
cellular response to oxygen levels
|
BCL2, PPARD, PTGS2, SRC, TERT |
2.34299 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.33424 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, GSK3B, IGF1R, SRC |
2.33174 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADORA2A, APP, AURKB, FABP3, IGF1R, KDR, MET, MMP12, PPARA, PPARD, PTGS2, RORC, SRC, TERT, TNKS, TNKS2, TOP2A |
2.31464 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLO1, GLRA1, GSK3B, HCAR2, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.29927 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.29678 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.28928 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, ADORA2A, AKR1B1, AKR1B10, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FLT3, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
2.28389 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, DNMT1, IGF1R, SRC, TNKS, TNKS2 |
2.28389 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.24057 |
[BP] GO:1901992 |
positive regulation of mitotic cell cycle phase transition
|
APEX1, APP, CYP1A1, TERT |
2.23628 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, PTGS2, SRC |
2.22259 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, DHFR, FLT3 |
2.22024 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, PPARD, PTGS2, SRC, TYR |
2.21039 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.19933 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.19933 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.17393 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, AXL, BCL2, CYP1A1, CYP1A2, GSK3B, IDO1, MMP12, PPARD, PTGS2, SRC |
2.16924 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA2A, ADORA3 |
2.15739 |
[BP] GO:0033032 |
regulation of myeloid cell apoptotic process
|
BCL2, HCAR2, MIF |
2.15739 |
[BP] GO:0031214 |
biomineral tissue development
|
ALOX15, ALPL, PPARA, PTGS2 |
2.1344 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, APP, CDC25B, CYP1A1, TERT |
2.11798 |
[BP] GO:0070229 |
negative regulation of lymphocyte apoptotic process
|
AURKB, IDO1, MIF |
2.11798 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, MIF, PTGS2 |
2.11798 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.11798 |
[BP] GO:0050730 |
None
|
ADORA1, APP, FLT3, MIF, PTPN1, SRC |
2.11798 |
[BP] GO:0014074 |
response to purine-containing compound
|
ADORA2A, APEX1, APP, PTGS2, TYR |
2.09803 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADORA2A, HCAR2, MIF, MMP12, PPARD, SRC |
2.09803 |
[BP] GO:0006091 |
generation of precursor metabolites and energy
|
AKR1B1, CYP19A1, CYP1A2, GSK3B, IDO1, PPARD, XDH |
2.09803 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, FLT3, IGF1R, KDR, MIF, PTPN1, SRC, XDH |
2.09234 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, MIF, TERT, TNKS |
2.0886 |
[BP] GO:0032204 |
None
|
AURKB, SRC, TNKS, TNKS2 |
2.08447 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.08447 |
[BP] GO:0072330 |
monocarboxylic acid biosynthetic process
|
ALOX15, CYP1A1, IDO1, MIF, PTGS2 |
2.08043 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
ADORA2A, CSNK2A1, MMP9, PTGS2, SRC, XDH |
2.08036 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
ADORA2A, APP, AURKB, DNMT1, IGF1R, MET, MMP12, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A |
2.07069 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.07069 |
[BP] GO:1901570 |
None
|
ALOX15, ALOX5, MIF, PTGS2 |
2.05248 |
[BP] GO:0032269 |
None
|
ADORA2A, APP, CSNK2A1, DHFR, DNMT1, FABP4, IGF1R, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
2.03996 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.03556 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AURKB, BACE1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, GSK3B, IDO1, PPARD, XDH |
2.02909 |
[BP] GO:0010760 |
negative regulation of macrophage chemotaxis
|
CYP19A1, MIF |
2.02678 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.02678 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.02678 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, HSD17B2, PPARD, PTGS2, SRC |
2.0125 |
[BP] GO:0051100 |
negative regulation of binding
|
AURKB, GSK3B, MET, PPARA, TNKS |
2.00838 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, PTGS2, SRC |
2.00838 |
[BP] GO:0003018 |
None
|
ADORA1, ADORA2A, PPARD, PTGS2, SRC |
2.00838 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, IDO1, PTGS2 |
2.00703 |
[CC] GO:0099055 |
None
|
ADORA1, ADORA2A, PTPRS |
3.4086 |
[CC] GO:0099699 |
None
|
ADORA1, ADORA2A, PTPRS |
3.4086 |
[CC] GO:0099240 |
None
|
ADORA1, ADORA2A, PTPRS |
3.4086 |
[CC] GO:0098936 |
None
|
ADORA1, ADORA2A, PTPRS |
3.4086 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLO1, GLRA1, GSK3B, IDO1, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH |
3.13321 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLO1, GLRA1, GSK3B, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH |
3.08224 |
[CC] GO:0099056 |
None
|
ADORA1, ADORA2A |
2.58419 |
[CC] GO:0098889 |
None
|
ADORA1, ADORA2A |
2.58419 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, APP, BCL2, CA4, CYP19A1, FLT3, GLRA1, KDR, PTGS2, PTPN1, XDH |
2.36403 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, ALOX15, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CSNK2A1, FLT3, GLO1, GLRA1, GSK3B, HCAR2, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, PTPRS, SRC, TERT |
2.24057 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, APP, AURKB, BACE1, BCL2, CA1, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FABP4, FLT3, GLO1, GLRA1, GSK3B, HSD17B1, HSD17B2, IDO1, KDR, MIF, MMP2, MMP9, PIM1, PTGS2, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
2.05248 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.02678 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FLT3, GLO1, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH |
13.1809 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, GLO1, GLRA1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, TNKS, TYR, XDH |
12.7375 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLO1, GLRA1, GSK3B, HSD17B1, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH |
11.915 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.22698 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD17B1, HSD17B2, IDO1, PTGS2, TYR, XDH |
6.92387 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, GLO1, GLRA1, IDO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
6.39538 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, DNMT1, GLO1, GLRA1, MMP1, MMP12, MMP2, MMP9, PPARA, PPARD, PTPN1, RORC, TNKS |
6.31988 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, GLO1, GLRA1, IDO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
6.05836 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7 |
5.67314 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DYRK1A, FLT3, GLRA1, GSK3B, IGF1R, KDR, MET, PIM1, PPARA, PPARD, SRC, TOP2A |
5.19872 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.08854 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, GLO1 |
4.39084 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2, SRC |
4.29764 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2, SRC |
4.10334 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.76185 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.72793 |
[MF] GO:0001609 |
None
|
ADORA1, ADORA2A, ADORA3 |
3.67535 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.58018 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.58018 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.54599 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.52158 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, AURKB, AXL, CSNK2A1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLRA1, GSK3B, HSD17B1, IGF1R, KDR, MET, PIM1, PPARD, SRC, TOP2A, TUBB3, XDH |
3.52144 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, FLT3, IGF1R, KDR, MET, SRC |
3.45677 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, APP, AURKB, AXL, CSNK2A1, DHFR, DYRK1A, FABP3, FABP4, FLT3, GLRA1, GSK3B, HSD17B1, IGF1R, KDR, MET, PIM1, PPARD, PTPRS, SRC, TOP2A, TUBB3, XDH |
3.31792 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD17B1, IDO1, PTGS2, SRC, XDH |
3.27385 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2, XDH |
3.1587 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.14343 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC |
3.0027 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TYR |
2.90324 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.85218 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.82615 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADORA2A, APP, BCL2, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, MET, MIF, MMP9, PTGS2, TERT, TOP2A, TYR, XDH |
2.78391 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.74339 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, IDO1, XDH |
2.60004 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.58419 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2 |
2.4472 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC |
2.40393 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
2.36403 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA2A, ADORA3 |
2.28761 |
[MF] GO:0005504 |
None
|
FABP3, FABP4, PPARD |
2.19933 |
[MF] GO:0051059 |
None
|
APEX1, GSK3B, PPARD |
2.15739 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC |
2.11798 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC, TERT |
2.11798 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DHFR, DNMT1, DYRK1A, FLT3, GSK3B, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, TOP2A, TUBB3, XDH |
2.08232 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AURKB, AXL, CSNK2A1, DHFR, DNMT1, DYRK1A, FLT3, GSK3B, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, TOP2A, TUBB3, XDH |
2.08086 |
[MF] GO:0008134 |
transcription factor binding
|
APEX1, BCL2, FLT3, GSK3B, PIM1, PPARA, PPARD, SRC, TERT |
2.05342 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.05248 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.02678 |